SYNTHESIS OF NOVEL CAMPHOR-DERIVED AMINES
(1R,3R,4R)-3-(3,5-Dimethylbenzyl)-1,7,7-trimethylbicyclo[2.2.1]
70mmol), and the resulting mixture was heated under reflux for 48h. Vola-
tile components were evaporated in vacuo, and to the residue, H2O was
added. The resulting precipitate was collected by filtration to give the prod-
uct as a mixture of epimers 6/6′. 6:6′ = 71:29. Yield: 1.37 g (96%) of white
solid; mp 132–146 ꢀC. [a]Dr.t. = +26.0 (c= 0.23, CHCl3). (C19H27NO requires:
C, 79.95; H, 9.53; N, 4.91. Found C, 80.17; H, 9.76; N, 4.88.);
EI-HRMS: m/z = 286.2180 (MH+); C19H28NO requires: m/z = 286.2171
(MH+); nmax (KBr) 3443, 3013, 2959, 2928, 1632, 1606, 1474, 1456, 1438,
1391, 1372, 1076, 930, 847, 738, 706, 673 cmÀ1 1H-NMR (500 MHz, CDCl3)
for 6: d 0.90 (s, Me); 1.03 (s, Me); 1.06 (s, Me); 1.11–1.17 (m, 1H of CH2);
1.40–1.47 (m, 1H of CH2); 1.61–1.70 (m, 1H of CH2); 1.74–1.79 (m, 1H
of CH2); 1.80 (d, J = 3.5 Hz, H-C(4)); 2.30 (s, 2ÂMe); 2.48 (dd, J = 10.0;
13.8 Hz, Ha-C(3′)); 2.67 (dd, J = 3.1; 9.9Hz, H-C(3)); 3.73 (dd, J = 2.9;
13.9 Hz, Hb-C(3′)); 6.84 (s, 1H of Arl); 6.89 (s, 2H of Arl); 7.59 (s, OH).
1H-NMR (500 MHz, CDCl3) for 6′: d 0.81 (s, Me); 0.89 (s, Me); 0.97
(s, Me); 1.47–1.53 (m, 1H of CH2); 2.29 (s, 2ÂMe); 2.42 (dd, J = 11.8;
14.3Hz, Ha-C(3′)); 3.17–3.24 (m, H-C(3)); 3.84 (dd, J= 4.2; 14.3Hz, Hb-C
(3′)); 6.82 (s, 1H of Arl); 6.86 (s, 2H of Arl). 13C-NMR (75 MHz, CDCl3)
for 6 and 6′: d 11.6, 12.1, 19.1, 19.3, 20.1, 21.0, 21.5, 22.6, 29.2, 32.1, 32.2,
33.5, 36.9, 43.1, 46.5, 47.5, 48.26, 48.33, 50.7, 53.1, 53.4, 126.8, 127.0,
127.57, 127.63, 137.8, 137.9, 141.0, 142.7, 170.1, 172.3.
heptan-2-one (4c), (1R,3S,4R)-3-(3,5-dimethylbenzyl)-1,7,7-
trimethylbicyclo[2.2.1]heptan-2-one (4c′), and (1R,2R,3R,4R)-3-(3,
5-dimethylbenzyl)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol (5c).
3c (4.39 g, 16.35 mmol); Pd–C (10%, 500 mg); t1 =20min; crude products:
4c:4c′:5c = 68:24:8, 100% conversion; MPLC (EtOAc/petroleum ether = 1:30).
4c/4c′: Elute first from the column. 4c/4c′ = 75:25. Yield: 3.46 g
(78%) of colorless oil. [a]rD.t. = +31.8 (c = 0.33, CHCl3). (C19H26O requires:
C, 84.39; H, 9.69. Found C, 83.67; H, 9.97.); EI-HRMS: m/z = 271.2065
(MH+); C19H27O requires: m/z = 271.2062 (MH+); nmax (NaCl) 2960,
2873, 1741, 1605, 1447, 1392, 1374, 1323, 1265, 1104, 1040, 1019, 943,
851, 712 cmÀ1 1H-NMR (500 MHz, CDCl3) for 4c: d 0.93 (s, Me); 0.94
.
(s, Me); 0.95 (s, Me); 1.22–1.28 (m, 1H of CH2); 1.45–1.52 (m, 1H of
CH2); 1.59–1.66 (m, 1H of CH2); 1.89–1.96 (m, 1H of CH2); 1.98 (d,
J = 4.0 Hz, H-C(4)); 2.13 (dd, J = 3.7; 10.5 Hz, H-C(3)); 2.29 (s, 2ÂMe);
2.43 (dd, J = 10.5; 14.0 Hz, Ha-C(3′)); 3.16 (dd, J = 3.6; 14.1 Hz, Hb-C(3′));
6.81 (s, 2H of Arl); 6.83 (s, 1H of Arl). 1H-NMR (500 MHz, CDCl3) for
4c′: d 0.85 (s, Me); 0.92 (s, Me); 0.96 (s, Me); 1.31–1.38 (m, 1H of
CH2); 1.66–1.73 (m, 1H of CH2); 1.74–1.80 (m, 2H of CH2); 2.28
(s, 2ÂMe); 2.65–2.71 (m, H-C(3)); 3.09 (dd, J = 4.3; 14.3 Hz, Hb-C(3′)).
13C-NMR (75 MHz, CDCl3) for 4c: d 9.6, 20.6, 21.4, 22.1, 29.4, 29.5,
37.3, 46.7, 46.9, 57.0, 57.7, 126.6, 127.8, 138.0, 141.4, 220.6. 13C-NMR
(75 MHz, CDCl3) for 4c′: d 9.7, 19.4, 19.7, 20.5, 31.1, 32.7, 45.8, 45.9,
52.0, 58.8, 126.4, 127.8, 137.9, 140.4, 220.4.
5c: Elutes second from the column. Yield: 193 mg (4%) of colorless
oil. [a]rD.t. = +16.7 (c = 0.20, CHCl3). EI-HRMS: m/z = 295.2029 (MNa+);
C19H28ONa requires: m/z = 295.2038 (MNa+); nmax (NaCl) 3499, 2950,
(1R,3R,4R,2E)-3-(3,5-Dimethylbenzyl)-1,7,7-trimethylbicyclo
[2.2.1]heptan-2-one O-acetyl oxime (7) and (1R,3S,4R,2E)-3-(3,5-
dimethylbenzyl)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one O-acetyl
oxime (7′). A solution of 6 (57mg, 0.2mmol, d.e. =42%) in Ac2O (0.5ml)
was heated at 80 ꢀC for 20 h. Volatile components were evaporated in vacuo.
The residue was dissolved and evaporated four times with PhMe (2 ml) and
four times with CH2Cl2 (2 ml) to azeotropically remove all traces of Ac2O. The
crude product 7/7′ was characterized without further purification.
7:7′ = 71:29. Yield: full conversion; colorless oil. EI-HRMS: m/z= 328.2286
(MH+); C21H30NO2 requires: m/z= 328.2277 (MH+); nmax (NaCl) 2962,
2874, 1765, 1651, 1606, 1448, 1391, 1365, 1206, 1042, 1001, 954, 922, 877,
1735, 1605, 1477, 1460, 1388, 1370, 1280, 1095, 1048, 848, 698 cmÀ1 1H-
.
NMR (500 MHz, CDCl3): d 0.80 (s, Me); 0.92 (s, Me); 0.95–1.08 (m, 2H
of CH2); 1.24 (s, Me); 1.43–1.50 (m, 1H of CH2); 1.55 (d, J = 3.8 Hz, H-C
(4)); 1.58 (d, J = 3.9 Hz, OH); 1.63–1.70 (m, 1H of CH2); 2.10 (q,
J = 8.1 Hz, H-C(3)); 2.29 (s, 2ÂMe); 2.69 (dd, J = 8.1; 14.2 Hz, Ha-C(3′));
3.02 (dd, J = 8.1; 14.2 Hz, Hb-C(3′)); 3.76 (dd, J = 3.6; 8.0 Hz, H-C(2));
6.81 (s, 1H of Arl); 6.86 (s, 2H of Arl). 13C-NMR (75 MHz, CDCl3): d
11.9, 21.5, 21.9, 22.3, 30.1, 33.8, 36.1, 47.1, 49.97, 50.03, 52.0, 82.0, 126.8,
127.4, 137.9, 143.2.
1
851 cmÀ1. H-NMR (300 MHz, CDCl3) for 7: d 0.93 (s, Me); 1.06 (s, Me);
(1R,3R,4R)-1,7,7-Trimethyl-3-(phenanthren-9-ylmethyl)bicyclo
[2.2.1]heptan-2-one (4d) and (1R,3S,4R)-1,7,7-trimethyl-3-
(phenanthren-9-ylmethyl)bicyclo[2.2.1]heptan-2-one (4d′). 3d
(1.69 g, 4.93 mmol); Pd–C (10%, 150 mg); t1 = 60min; 100% conversion;
MPLC (EtOAc/petrol ether= 1:30). 4d:4d′ = 72:28. Yield: 1.48g (87%) of
1.15 (s, Me); 1.15–1.23 (m, 1H of CH2); 1.46–1.56 (m, 1H of CH2);
1.65–1.81 (m, 2H of CH2); 1.84 (d, J= 3.6 Hz, H-C(4)); 2.13 (s, OAc); 2.31
(s, 2ÂMe); 2.59 (dd, J=9.3; 13.9Hz, Ha-C(3′)); 2.72 (dd, J=3.2; 9.3Hz,
H-C(3)); 3.42 (dd, J=3.1; 13.9Hz, Hb-C(3′)); 6.82 (s, 1H of Arl); 6.85
(s, 2H of Arl). 1H-NMR (300 MHz, CDCl3) for 7′: d 0.84 (s, Me); 1.08
(s, Me); 2.13 (s, OAc); 2.30 (s, 2ÂMe); 2.49 (dd, J= 11.3; 14.3 Hz, Ha-C
(3′)); 3.21–3.30 (m, H-C(3)); 3.53 (dd, J=4.6; 14.4Hz, Hb-C(3′)). 13C-NMR
(75 MHz, CDCl3) for 7 and 7′: d 11.4, 11.9, 19.0, 19.2, 19.88, 19.94, 20.8,
21.5, 22.6, 28.9, 31.8, 33.0, 33.3, 38.2, 44.1, 46.5, 47.8, 48.5, 48.7, 51.5,
54.3, 54.6, 126.5, 126.6, 127.9, 128.0, 138.06, 138.15, 140.0, 141.8, 168.9,
169.0, 178.0, 180.3.
white solid; mp 49.2–62.0 ꢀC. [a]Dr.t. = +55.8 (c= 0.10, CH2Cl2). (C25H26
O
requires: C, 87.68; H, 7.65. Found C, 87.42; H, 7.84.); EI-HRMS:
m/z = 343.2061 (MH+); C25H27O requires: m/z = 343.2062 (MH+); nmax
(KBr) 3061, 2957, 2931, 2874, 2365, 2336, 1738, 1607, 1487, 1448, 1265,
1016, 887, 747, 668 cmÀ1 1H-NMR (CDCl3, 300MHz) for 4d: d 0.98
.
(s, Me); 0.99 (s, Me); 1.09 (s, Me); 1.10–1.19 (m, 1H of CH2); 1.42–1.52
(m, 1H of CH2); 1.59–1.70 (m, 1H of CH2); 1.84–1.96 (m, 1H of CH2);
2.10 (d, J = 4.0 Hz, H-C(4)); 2.32 (dd, J = 2.9; 9.9 Hz, H-C(3)); 2.90 (dd,
J= 10.0; 14.6 Hz, Ha-C(3′)); 3.85 (dd, J= 2.7; 14.4 Hz, Hb-C(3′)); 7.53–7.71
(m, 5H of Arl); 7.80–7.87 (m, 1H of Arl); 8.23–8.29 (m, 1H of Arl),
8.63–8.79 (m, 2H of Arl). 1H-NMR (CDCl3, 300MHz) for 4d′: d 0.81
(s, Me); 0.97 (s, 2ÂMe); 1.72–1.82 (m, 1H of CH2); 1.97–2.01 (m, H-C(4));
2.93–3.01 (m, H-C(3), Ha-C(3′)); 3.68–3.79 (m, Hb-C(3′)); 8.16–8.23 (m, 1H
of Arl). 13C-NMR (126 MHz, CDCl3) for 4d: d 9.7, 20.6, 22.3, 29.2, 29.4,
35.6, 47.2, 47.3, 55.2, 57.9, 122.6, 123.4, 124.7, 126.3, 126.5, 126.8, 126.9,
127.1, 128.2, 130.1, 130.8, 131.1, 131.8, 135.6, 221.0. 13C-NMR (126MHz,
CDCl3) for 4d′: d 9.8, 15.5, 19.5, 19.7, 20.6, 30.2, 31.3, 46.0, 46.3, 50.6, 59.0,
66.0, 122.6, 123.5, 124.4, 126.5, 126.7, 127.0, 129.9, 130.98, 131.01, 131.8,
134.6, 220.8.
3-(3,5-Dimethylphenyl)-2-(2,3,3-trimethylcyclopent-1-en-1-yl)
propanenitrile (8). To a solution of 6 (57 mg, 0.2 mmol, d.e. = 42%) in a
mixture of TFA (120 ml) and toluene (80 ml) was added 2,4,6-trichloro-1,3,
5-triazine (2.9 mg), and the resulting mixture was heated at 70 ꢀC for 1h.
Volatile components were evaporated in vacuo, and the residue was purified
by column chromatography (EtOAc/petroleum ether = 1:100). Fractions
containing the product were combined, and volatile components evaporated
in vacuo to give 8 in approximately 85% purity. Yield: 27 mg (43%, o ꢁ 0.85)
of colorless oil. EI-HRMS: m/z= 268.2065 (MH+); C19H26N requires:
m/z= 268.2065 (MH+); nmax (NaCl) 3015, 2955, 2934, 2863, 2238, 1767,
1660, 1607, 1459, 1379, 1361, 1207, 1163, 851, 704 cmÀ1 1H-NMR
.
(500 MHz, CDCl3): d 0.87 (s, Me); 0.96 (s, Me); 1.23 (t, J=2.0Hz, Me);
1.62–1.71 (m, H2-C(4)); 2.27 (s, 2ÂMe); 2.29–2.36 (m, Ha-C(5)); 2.36–2.44
(m, Hb-C(5)); 2.76 (dd, J=8.4; 13.3Hz, Ha-C(2′)); 3.00 (dd, J= 7.0; 13.3Hz,
Hb-C(2′)); 3.61 (dd, J=7.1; 8.2Hz, H-C(1′)); 6.77 (s, 2H of Arl); 6.87 (s, 1H
of Arl). 13C-NMR (126 MHz, CDCl3): d 9.6, 21.4, 26.26, 26.32, 30.1, 33.2,
37.9, 38.5, 47.5, 120.8, 125.9, 127.0, 128.8, 137.0, 138.1, 145.1.
(1R,3R,4R,2E)-3-(3,5-Dimethylbenzyl)-1,7,7-trimethylbicyclo
[2.2.1]heptan-2-one oxime (6) and (1R,3S,4R,2E)-3-(3,5-
dimethylbenzyl)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
oxime (6′). To a solution of 4c (1.35g, 5 mmol; d.e. = 50%) in EtOH
(30ml) were added pyridine (4.04ml, 50mmol) and NH2OH–HCl (4.86g,
Chirality DOI 10.1002/chir